At Everest Pharmacy, we understand how important it is for our patients to stay informed about developments in medical weight loss treatment. If you’ve been following the latest updates in obesity care, you may have come across a new name causing quite a stir: Amycretin. This emerging medication, still in the development phase, is showing remarkable early results and could soon be part of the wider toolkit for weight management.

As a leading weight loss clinic in Manchester, we’re keeping a close eye on Amycretin’s progress and what it could mean for patients across the region looking for evidence-based support in achieving long-term health improvements.

What Is Amycretin and Who Is Behind It?

Amycretin is a new investigational treatment currently being developed by Novo Nordisk, the same pharmaceutical company that manufactures Wegovy and Ozempic, both well-known for their use in treating obesity and type 2 diabetes.

Unlike previous treatments that focus on a single biological pathway, Amycretin acts on two hormone receptors in the body. Specifically, it targets GLP-1 (glucagon-like peptide-1) and the amylin receptor. These are both involved in regulating feelings of fullness, slowing digestion, and balancing blood sugar levels. By stimulating both receptors, Amycretin could potentially offer more effective appetite suppression and metabolic benefits than existing treatments.

Clinical Findings So Far

Recent data published in The Lancet sheds light on how powerful Amycretin could be. In an early-stage clinical trial involving 125 adults, participants received weekly injections of the medication over the course of 36 weeks. Those who were given the highest dose—60mg per week—reported an average body weight reduction of 24.3% during the trial.

This level of weight reduction surpasses what is typically seen in other injectable weight loss drugs currently available. In addition to the weight-related results, improvements were also observed in blood glucose regulation, making the medication potentially beneficial for individuals with insulin resistance or at risk of developing diabetes.

While these results are extremely promising, it’s important to note that Amycretin is not yet approved or available for prescription. More extensive studies are required to understand the long-term safety profile, optimal dosing strategy, and whether the treatment can be offered in pill form in the future.

How Is Amycretin Different?

While drugs like semaglutide (Wegovy) work by mimicking GLP-1 to control appetite and slow digestion, Amycretin introduces a second mechanism of action through the amylin pathway, which may enhance and extend satiety even further. This dual-approach design could make it especially effective for individuals who have not achieved significant results with single-agent medications.

It also opens the door for a more personalised approach to treatment, depending on the patient’s health history, weight loss goals, and response to previous therapies.

Why This Matters to Manchester Patients

Obesity is a serious and complex condition that affects people across all backgrounds and lifestyles. As a trusted weight loss clinic in Manchester, we see every day how difficult it can be to lose weight and keep it off, especially when lifestyle changes alone don’t deliver the desired results.

The emergence of new, clinically backed treatments like Amycretin could significantly expand the choices available for people who’ve struggled with traditional methods or haven’t been suitable for existing medications.

Even though Amycretin is still undergoing research, it represents a step forward in addressing the growing need for accessible, long-term weight management solutions.

What Can You Do Now?

While Amycretin is still some way from being released, there are safe, regulated treatments already available that may be right for you. At Everest Pharmacy, we provide comprehensive Greater Manchester weight management support, including:

• –> Personalised consultations and goal setting

• –> Access to clinically licensed treatments such as Wegovy or Saxenda (subject to availability and medical suitability)

• –> Diet and exercise guidance tailored to your lifestyle

• –> Ongoing support to keep you motivated and on track

We believe that the best outcomes come from combining medical treatment with practical lifestyle changes, and our team is here to guide you every step of the way. Contact us to find out more.

Looking Ahead

The future of weight loss medicine is evolving rapidly. With drugs like Amycretin showing promise, there’s hope for more targeted and effective options shortly. If approved, it could offer new hope for thousands of people in Greater Manchester and beyond who are looking for a safe, science-backed way to achieve better health.

At Everest Pharmacy, we’re committed to staying informed about innovations in obesity care and ensuring that our patients have access to the most effective and up-to-date treatments available.

If you’re interested in learning more about weight loss support or want to explore your current options, we invite you to book a consultation at our clinic.

Together, we can find the right path to help you achieve a healthier, more confident future.

This blog was written on behalf of Everest Pharmacy by Pharmacy Mentor.